Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Rangwala Reshma Create: Alert

All | News | Filings
Date FiledTypeDescription
04/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2023 4 Rangwala Reshma (EVP & Chief Medical Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 100,000 shares @ $0
05/02/2022 4 Rangwala Reshma (EVP & Chief Medical Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 65,000 shares @ $0
Granted 100,000 options to buy @ $6.1, valued at $610k
04/29/2022 3 Rangwala Reshma (EVP & Chief Medical Officer) has filed a Form 3 on Karyopharm Therapeutics Inc.
01/25/2022 4 Rangwala Reshma (Chief Medical Officer) has filed a Form 4 on Aravive, Inc.
Txns: Granted 175,000 options to buy @ $2.18, valued at $381.5k
01/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2020 4 Rangwala Reshma (Chief Medical Officer) has filed a Form 4 on Aravive, Inc.
Txns: Granted 75,000 options @ $4.95, valued at $371.3k
09/29/2020 3 Rangwala Reshma (Chief Medical Officer) has filed a Form 3 on Aravive, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy